These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting mortality of refractory status epilepticus. Tatlidil I; Ture HS; Akhan G Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052 [TBL] [Abstract][Full Text] [Related]
7. Refractory status epilepticus: a developing country perspective. Sinha S; Prashantha DK; Thennarasu K; Umamaheshwara Rao GS; Satishchandra P J Neurol Sci; 2010 Mar; 290(1-2):60-5. PubMed ID: 19954801 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of endosulfan poisoning: a study of 23 cases. Karatas AD; Aygun D; Baydin A Singapore Med J; 2006 Dec; 47(12):1030-2. PubMed ID: 17139397 [TBL] [Abstract][Full Text] [Related]
9. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country. Dubey D; Bhoi SK; Kalita J; Misra UK Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263 [TBL] [Abstract][Full Text] [Related]
10. Acute intentional toxicity: endosulfan and other organochlorines. Moses V; Peter JV Clin Toxicol (Phila); 2010 Jul; 48(6):539-44. PubMed ID: 20572757 [TBL] [Abstract][Full Text] [Related]
11. Unintentional toxicity due to endosulfan: a case report of two patients and characteristics of endosulfan toxicity. Oktay C; Goksu E; Bozdemir N; Soyuncu S Vet Hum Toxicol; 2003 Dec; 45(6):318-20. PubMed ID: 14640485 [TBL] [Abstract][Full Text] [Related]
12. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. Holtkamp M; Othman J; Buchheim K; Meierkord H J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441 [TBL] [Abstract][Full Text] [Related]
14. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus. Choi JY; Hong JM; Kim TJ; Kim BG; Huh K Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771 [TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in refractory status epilepticus. Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514 [TBL] [Abstract][Full Text] [Related]
16. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study. Kantanen AM; Sairanen J; Kälviäinen R Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204 [TBL] [Abstract][Full Text] [Related]
17. Aborted and refractory status epilepticus in children: a comparative analysis. Lambrechtsen FA; Buchhalter JR Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148 [TBL] [Abstract][Full Text] [Related]
19. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy. Jayalakshmi S; Vooturi S; Sahu S; Yada PK; Mohandas S J Clin Neurosci; 2016 Apr; 26():89-94. PubMed ID: 26822381 [TBL] [Abstract][Full Text] [Related]
20. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Dhote F; Carpentier P; Barbier L; Peinnequin A; Baille V; Pernot F; Testylier G; Beaup C; Foquin A; Dorandeu F Toxicol Appl Pharmacol; 2012 Mar; 259(2):195-209. PubMed ID: 22245128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]